New peptide to improve healing of diabetic wounds
Novel peptide for enhancing diabetic wound healing
This study is testing a new treatment to help heal stubborn wounds in people with diabetes, aiming to speed up healing and reduce complications by improving how the body repairs itself.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scarless Laboratories, INC. NIH-funded |
| Lab location | 1 site (Beverly Hills, United States) |
| Project ID | NIH-10814133 on NIH RePORTER |
What this research studies
This research focuses on developing a novel peptide that aims to enhance the healing process of chronic wounds in diabetic patients. It addresses the challenges faced by individuals with diabetes, who often suffer from non-healing ulcers due to impaired cellular functions and poor blood flow. The approach involves restoring the molecular and cellular processes necessary for effective wound repair, potentially leading to faster healing and reduced risk of complications. Patients participating in this research may receive treatments that directly target the underlying issues affecting their wound healing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with diabetes who are experiencing chronic non-healing wounds.
Not a fit: Patients without diabetes or those with acute wounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the healing rates of diabetic wounds, reducing the risk of infections and amputations.
How similar studies have performed: Previous research has shown promise in using novel peptides for wound healing, indicating that this approach could be effective.
Where this research is happening
Beverly Hills, United States
- Scarless Laboratories, INC. — Beverly Hills, United States (Active)
Researchers
- Principal investigator: Zheng, Zhong — Scarless Laboratories, INC.
- Study coordinator: Zheng, Zhong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.